Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AXR-159 in Dry Eye Disease
NCT03598699Phase 2Completed
- Sponsor
- AxeroVision, Inc.
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AXR-159 in dry eye disease (DED), sponsored by AxeroVision, Inc.. Started Jun 2018; status: completed.
02
Drugs
AXR-159
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT03598699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03598699.